Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Follow-Up Questions
Carlsmed Inc のCEOは誰ですか？
Mr. Michael Cordonnier は Carlsmed Inc の Chairman of the Board で、2018 から在籍しています。
CARL の株価パフォーマンスは？
CARL の現在の価格は $13.47 で、最終取引日から 0.03% decreased 変動しました。
Carlsmed Inc の主な事業テーマや業界は？
Carlsmed Inc は Health Care 業界、セクターは Health Care に属しています。
